Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02132312 · ClinicalTrials.gov registry record · Phase 3
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
A Phase 3 study, sponsored by Omeros Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 78
- Enrollment target
NCT02132312 is a Phase 3 study that has completed, run by Omeros Corporation. The registered enrollment target is 78 participants.
The verdict
NCT02132312, a Phase 3 study, has completed, sponsored by Omeros Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 78 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of OMS302 compared to phenylephrine when administered in irrigation solution during cataract extraction on intraoperative pupil diameter, acute postoperative pain, and safety in children birth through 3 years.
Interventions
- DRUG OMS302
- DRUG Phenylephrine HCl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-09-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02132312
The ClinicalTrials.gov registry entry for NCT02132312 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Omeros Corporation, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which OMS302 is the first listed.
NCT02132312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02132312 about?
NCT02132312 is a clinical study titled "A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement". The purpose of this study is to evaluate the effect of OMS302 compared to phenylephrine when administered in irrigation solution during cataract extraction on intraoperative pupil diameter, acute postoperative pain, and safety in children birth through 3 years.
What is the current status of trial NCT02132312?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 78 participants. The study started on 2014-07. Estimated completion is 2016-09-12.
What interventions are being tested in trial NCT02132312?
The interventions under investigation include: OMS302 (DRUG), Phenylephrine HCl (DRUG).
Who is sponsoring clinical trial NCT02132312?
This trial is sponsored by Omeros Corporation, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.